{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:30:33Z","timestamp":1760711433317,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12328-024-02043-5","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T18:02:07Z","timestamp":1728928927000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A case of MSI-high pancreatic body-tail cancer successfully treated with radical resection after pembrolizumab"],"prefix":"10.1007","volume":"18","author":[{"given":"Miki","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Oga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Nagamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaku","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-1911","authenticated-orcid":false,"given":"Tsutomu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"2043_CR1","unstructured":"Pharmaceuticals and Medical Devices Agency.https:\/\/www.pmda.go.jp\/review-services\/drug-reviews\/review-information\/p-drugs\/0028.html. Accessed 17 Jul 2024."},{"key":"2043_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/cas.14798","volume":"112","author":"K Akagi","year":"2021","unstructured":"Akagi K, Oki E, Taniguchi H, et al. Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors. Cancer Sci. 2021;112:1105\u201313.","journal-title":"Cancer Sci"},{"key":"2043_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/PDM.0b013e3182461cc3","volume":"21","author":"DT Patil","year":"2012","unstructured":"Patil DT, Bronner MP, Portier BP, et al. A five-marker panel in a multiplex PCR accurately detects microsatellite instability-high colorectal tumors without control DNA. Diagn Mol Pathol. 2012;21:127\u201333.","journal-title":"Diagn Mol Pathol"},{"key":"2043_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","volume":"32","author":"LA Diaz Jr","year":"2014","unstructured":"Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32:579\u201386.","journal-title":"J Clin Oncol"},{"key":"2043_CR5","doi-asserted-by":"publisher","first-page":"e004485","DOI":"10.1136\/jitc-2021-004485","volume":"10","author":"S Chakrabarti","year":"2022","unstructured":"Chakrabarti S, Bucheit L, Starr JS, et al. Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer. J Immunother Cancer. 2022;10:e004485.","journal-title":"J Immunother Cancer"},{"key":"2043_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Le DT, Ascierto PA, et al. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2020;38:1\u201310.","journal-title":"J Clin Oncol"},{"key":"2043_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409\u201313.","journal-title":"Science"},{"key":"2043_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJMp1709968","volume":"377","author":"S Lemery","year":"2017","unstructured":"Lemery S, Keegan P, Pazdur R. First FDA approval agnostic of cancer site-when a biomarker defines the indication. N Engl J Med. 2017;377:1409\u201312.","journal-title":"N Engl J Med"},{"key":"2043_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/SLA.0000000000005430","volume":"275","author":"J Yamaguchi","year":"2022","unstructured":"Yamaguchi J, Yokoyama Y, Fujii T, et al. Results of a phase II study on the use of neoadjuvant chemotherapy (FOLFIRINOX or GEM\/nab-PTX) for borderline-resectable pancreatic cancer (NUPAT-01). Ann Surg. 2022;275:1043\u20139.","journal-title":"Ann Surg"},{"key":"2043_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.pan.2023.07.005","volume":"23","author":"D Hashimoto","year":"2023","unstructured":"Hashimoto D, Satoi S, Fujii T, et al. Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? a position paper by experts in pancreatic surgery at the joint meeting of the international association of pancreatology (IAP) & the Japan pancreas society (JPS) 2022 in Kyoto. Pancreatology. 2023;23:682\u20138.","journal-title":"Pancreatology"},{"key":"2043_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/jhbp.1303","volume":"30","author":"M Nagai","year":"2023","unstructured":"Nagai M, Wright MJ, Ding D, et al. Oncologic resection of pancreatic cancer with isolated liver metastasis: favorable outcomes in select patients. J Hepatobiliary Pancreat Sci. 2023;30:1025\u201335.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"2043_CR12","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1097\/SLA.0000000000005481","volume":"277","author":"T Hank","year":"2023","unstructured":"Hank T, Klaiber U, Hinz U, et al. Oncological outcome of conversion surgery after preoperative chemotherapy for metastatic pancreatic cancer. Ann Surg. 2023;277(5):e1089\u201398.","journal-title":"Ann Surg"},{"key":"2043_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12957-022-02661-8","volume":"20","author":"Y Hidaka","year":"2022","unstructured":"Hidaka Y, Arigami T, Osako Y, et al. Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report. World J Surg Oncol. 2022;20:193.","journal-title":"World J Surg Oncol"},{"key":"2043_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.21037\/atm-22-3769","volume":"10","author":"S Zhang","year":"2022","unstructured":"Zhang S, Huang Y, Chen M, et al. Immunochemotherapy includes pembrolizumab for stage IIIB lung squamous cell carcinoma: a case report. Ann Transl Med. 2022;10:1028.","journal-title":"Ann Transl Med"},{"key":"2043_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jtcvs.2021.02.099","volume":"163","author":"BC Tong","year":"2022","unstructured":"Tong BC, Gu L, Wang X, et al. Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2022;163:427\u201336.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2043_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14701\/ahbps.22-078","volume":"27","author":"M Lee","year":"2023","unstructured":"Lee M, Cho YJ, Jung H-S, et al. Collective review of pancreatic carcinosarcoma, a very rare pancreatic malignancy. Ann Hepatobiliary Pancreat Surg. 2023;27:141\u201350.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2043_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40792-023-01634-7","volume":"9","author":"T Kawazoe","year":"2023","unstructured":"Kawazoe T, Ito S, Ohgaki K, et al. Successful conversion surgery following chemotherapy with an immune checkpoint inhibitor in an older adult patient with stage IVB esophageal squamous cell carcinoma: a case report. Surg Case Rep. 2023;9:51.","journal-title":"Surg Case Rep"},{"key":"2043_CR18","unstructured":"Guidelines for peritoneal disseminated disease. 2021 edition; 2021:99.https:\/\/fukumakuhashu.jp\/guideline.html. Accessed 17 Jul 2024."},{"key":"2043_CR19","first-page":"1880","volume":"44","author":"Y Kyakumoto","year":"2017","unstructured":"Kyakumoto Y, Takadate T, Mizuma M, et al. A case of successful adjuvant surgery for the pancreas head cancer with peritoneal metastasis. Gan To Kagaku Ryoho. 2017;44:1880\u20132.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2043_CR20","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/bjs.11792","volume":"107","author":"S Yamada","year":"2020","unstructured":"Yamada S, Fujii T, Yamamoto T, et al. Phase I\/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis. Br J Surg. 2020;107:1811\u20137.","journal-title":"Br J Surg"},{"key":"2043_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/jhbp.1356","volume":"30","author":"M Fukasawa","year":"2023","unstructured":"Fukasawa M, Watanabe T, Tanaka H, et al. Efficacy of staging laparoscopy for resectable pancreatic cancer on imaging and the therapeutic effect of systemic chemotherapy for positive peritoneal cytology. J Hepatobiliary Pancreat Sci. 2023;30:1261\u201372.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2043_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ags3.12719","volume":"8","author":"T Igarashi","year":"2023","unstructured":"Igarashi T, Fukasawa M, Watanabe T, et al. Evaluating staging laparoscopy indications for pancreatic cancer based on resectability classification and treatment strategies for patients with positive peritoneal washing cytology. Ann Gastroenterol Surg. 2023;8:124\u201332.","journal-title":"Ann Gastroenterol Surg"},{"key":"2043_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ags3.12613","volume":"7","author":"T Igarashi","year":"2022","unstructured":"Igarashi T, Yamada S, Hoshino Y, et al. Prognostic factors in conversion surgery following nab-paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: results of a dual-center study. Ann Gastroenterol Surg. 2022;7:157\u201366.","journal-title":"Ann Gastroenterol Surg"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02043-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:16:41Z","timestamp":1738329401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02043-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02043-5","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"14 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), the Helsinki Declaration of 1964, and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"Informed consent was obtained from this patient to be included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}